[Value of percutaneous hepatic biopsy in the diagnosis of presumed benign tumors of the liver].
The purpose of this study was to assess the accuracy of guided hepatic biopsy (GHB) and imaging techniques for presumed benign liver tumours and to determine their impact on surgical treatment. The study was carried out retrospectively in a surgical series of 15 consecutive patients with presumed benign liver tumours. The final diagnosis was 8 cases of focal nodular hyperplasia (FNH), 6 hepatic adenomas (HA) and one association FNH-HA. No morbidity was related to guided hepatic biopsy. All FNH detected on radiologic imaging or pathological examination of the biopsy specimen were true positive diagnoses. This study demonstrates that combined results of imaging techniques and percutaneous GHB could correctly diagnose three quarters of FNH before surgery. GHB is also useful when MRI imaging is indeterminate allowing a conservative approach for undiagnosed FNH.
Khiari
A
A
Service de Chirurgie Digestive C, Hôpital Saint-Eloi, Montpellier.
Navarro
F
F
Fabre
J M
JM
Duchene
D
D
Quenet
F
F
Ducatez
C
C
Ramos
J
J
Pradel
J
J
Domergue
J
J
D018248:Adenoma, Liver Cell / Q000473:pathology; D000328:Adult; D001707:Biopsy, Needle; D003581:Cytodiagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012680:Sensitivity and Specificity